Medicine:Neurocysticercosis

From HandWiki
Short description: Cysticercosis of the brain
Neurocysticercosis
Neurocysticercosis.gif
Magnetic resonance image of a patient with neurocysticercosis demonstrating multiple cysticerci within the brain.
SpecialtyInfectious disease
Diagnostic methodCT scan

Neurocysticercosis /ˈnjʊəroʊˌsɪstiˌsɜːrˈkoʊsɪs/ is a specific form of the infectious parasitic disease cysticercosis that is caused by the infection with Taenia solium, a tapeworm found in pigs. Neurocysticercosis occurs when cysts formed by the infection take hold within the brain, causing neurologic syndromes such as epileptic seizures. It is a common cause of seizures worldwide. It has been called a "hidden epidemic"[1] and "arguably the most common parasitic disease of the human nervous system".[2] Common symptoms of neurocysticercosis include seizures, headaches, blindness, meningitis and dementia.[3]

Signs and symptoms

Neurocysticercosis is associated with a wide variety of neurologic symptoms due to its ability to present in diverse areas of the central nervous system.[4] The symptoms of neurocysticercosis largely depend on the number and location of cysts, as well as the host immune response to the parasite.[5] The most common clinical manifestations include seizures, intracranial hypertension, focal deficits, and cognitive alterations.[4]

Pathophysiology

Neurocysticercosis most commonly involves the cerebral cortex followed by the cerebellum. The pituitary gland is very rarely involved in neurocysticercosis. The cysts may rarely coalesce and form a tree-like pattern which is known as racemose neurocysticercosis, which when involving the pituitary gland may result in multiple pituitary hormone deficiency.[6]

Diagnosis

Neurocysticercosis is diagnosed by computed tomography (CT) scan.[3] Diagnosis may be confirmed by detection of antibodies against cysticerci in CSF or serum[7] through ELISA or immunoblotting techniques.[8]

Treatment

Treatment of neurocysticercosis includes epileptic therapy and a long-course medication of praziquantel (PZQ) and/or albendazole.[3] Steroid therapy may be necessary to minimize the inflammatory reaction to dying cysticerci.[8] Surgical removal of brain cysts may be necessary,[8] e.g. in cases of large parenchymal cysts, intraventricular cysts or hydrocephalus.[9]

Albendazole has been shown to reduce seizure recurrence in those with a single non-viable intraparenchymal cyst.[10] For seizures further randomized controlled trials are needed to evaluate the efficacy of antiepileptic drugs (AED) for seizure prevention in patients with symptoms other than seizures and the duration of AED treatment in these cases.[11]

Epidemiology

The epidemiology of Taenia solium cysticercosis is associated with poor sanitation and is highly prevalent in Sub-Saharan Africa, Latin America and Asia.[12][13][14] Cysticercosis in the United States, which commonly presents in the form of neurocysticercosis, has been classified as a "neglected tropical disease",[15] which commonly affects the poor and homeless, particularly those without access or in the habit of inadequate hand-washing and in the habit of eating with their hands.[citation needed]

References

  1. ↑ Zimmer, Carl (15 May 2012). "Hidden Epidemic: Tapeworms Living Inside People's Brains". Discover Magazine. https://www.discovermagazine.com/health/hidden-epidemic-tapeworms-living-inside-peoples-brains. 
  2. ↑ White, A. C. (1997). "Neurocysticercosis: A Major Cause of Neurological Disease Worldwide". Clinical Infectious Diseases 24 (2): 101–13; quiz 114–5. doi:10.1093/clinids/24.2.101. PMID 9114131. 
  3. ↑ 3.0 3.1 3.2 "WHO | 10 facts about neurocysticercosis". https://www.who.int/features/factfiles/neurocysticercosis/en/. 
  4. ↑ 4.0 4.1 Garcia, Hector H. (2018-11-01). "Neurocysticercosis" (in en). Neurologic Clinics. Neuro-Infectious Diseases 36 (4): 851–864. doi:10.1016/j.ncl.2018.07.003. ISSN 0733-8619. PMID 30366559. https://www.sciencedirect.com/science/article/pii/S0733861918312441. 
  5. ↑ Carpio, Arturo (December 2002). "Neurocysticercosis: an update". The Lancet Infectious Diseases 2 (12): 751–762. doi:10.1016/s1473-3099(02)00454-1. ISSN 1473-3099. PMID 12467692. https://doi.org/10.1016/S1473-3099(02)00454-1. 
  6. ↑ Dutta, Deep; Kumar, Mano; Ghosh, Sujoy; Mukhopadhyay, Satinath; Chowdhury, Subhankar (2013). "Pituitary hormone deficiency due to racemose neurocysticercosis". The Lancet Diabetes & Endocrinology 1 (2): e13. doi:10.1016/S2213-8587(13)70026-3. PMID 24622323. 
  7. ↑ Proaño-Narvaez, J. V.; Meza-Lucas, A.; Mata-Ruiz, O.; Garcia-Jerónimo, R. C.; Correa, D. (June 2002). "Laboratory Diagnosis of Human Neurocysticercosis: Double-Blind Comparison of Enzyme-Linked Immunosorbent Assay and Electroimmunotransfer Blot Assay". J Clin Microbiol 40 (6): 2115–2118. doi:10.1128/JCM.40.6.2115-2118.2002. PMID 12037074. 
  8. ↑ 8.0 8.1 8.2 Murray, P.; Rosenthal, K.; Pfaller, M. (2013). "Chapter 85 — Cestodes". Medical Microbiology (7th ed.). Philadelphia, PA, USA: Elsevier Saunders. p. 809. ISBN 978-0-323-08692-9. 
  9. ↑ Rajshekhar (4 January 2010). "Surgical management of neurocysticercosis". International Journal of Surgery 8 (2): 100–104. doi:10.1016/j.ijsu.2009.12.006. PMID 20045747. 
  10. ↑ Monk, Edward J. M.; Abba, Katharine; Ranganathan, Lakshmi N. (2021-06-01). "Anthelmintics for people with neurocysticercosis". The Cochrane Database of Systematic Reviews 2021 (6): CD000215. doi:10.1002/14651858.CD000215.pub5. ISSN 1469-493X. PMID 34060667. 
  11. ↑ Frackowiak, Marta; Sharma, Monika; Singh, Tejinder; Mathew, Amrith; Michael, Benedict D. (2019-10-14). "Antiepileptic drugs for seizure control in people with neurocysticercosis". The Cochrane Database of Systematic Reviews 10 (10): CD009027. doi:10.1002/14651858.CD009027.pub3. ISSN 1469-493X. PMID 31608991. 
  12. ↑ Flisser, Ana; Sarti, Elsa; Lightowlers, Marshall; Schantz, Peter (2003-06-01). "Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas". Acta Tropica. International Action Planning Workshop on Taenia Solium Cysticercosis/Taeniosis with Special Focus on Eastern and Southern Africa. 87 (1): 43–51. doi:10.1016/S0001-706X(03)00054-8. PMID 12781377. 
  13. ↑ Mwanjali, Gloria; Kihamia, Charles; Kakoko, Deodatus Vitalis Conatus; Lekule, Faustin; Ngowi, Helena; Johansen, Maria Vang; Thamsborg, Stig Milan; Iii, Arve Lee Willingham (2013-03-14). "Prevalence and Risk Factors Associated with Human Taenia Solium Infections in Mbozi District, Mbeya Region, Tanzania". PLOS Neglected Tropical Diseases 7 (3): e2102. doi:10.1371/journal.pntd.0002102. ISSN 1935-2735. PMID 23516650. 
  14. ↑ Schantz, Peter M.; Moore, Anne C.; Muñoz, José L.; Hartman, Barry J.; Schaefer, John A.; Aron, Alan M.; Persaud, Deborah; Sarti, Elsa et al. (1992-09-03). "Neurocysticercosis in an Orthodox Jewish Community in New York City". New England Journal of Medicine 327 (10): 692–695. doi:10.1056/NEJM199209033271004. ISSN 0028-4793. PMID 1495521. 
  15. ↑ Hotez, Peter J. (2014). "Neglected Parasitic Infections and Poverty in the United States". PLOS Neglected Tropical Diseases 8 (9): e3012. doi:10.1371/journal.pntd.0003012. PMID 25188455. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Neurocysticercosis&oldid=3274327"